Orchid Pharma
Orchid Pharma Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Orchid Pharma
Start SIPOrchid Pharma Investment Rating
-
Master Rating:
-
Orchid Pharma has an operating revenue of Rs. 634.13 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of -10% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -8% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 160 | 165 | 131 | 180 |
| Operating Expenses Qtr Cr | 146 | 147 | 119 | 151 |
| Operating Profit Qtr Cr | 14 | 18 | 12 | 29 |
| Depreciation Qtr Cr | 8 | 18 | 22 | 27 |
| Interest Qtr Cr | 8 | 9 | 8 | 4 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 7 | -3 | -14 | -2 |
Orchid Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- 394.21
- 50 Day
- 390.12
- 100 Day
- 381.09
- 200 Day
- 375.86
- 20 Day
- 394.9
- 50 Day
- 387.09
- 100 Day
- 387.2
- 200 Day
- 353.47
Orchid Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 398.2 |
| Second Resistance | 409.5 |
| Third Resistance | 421.1 |
| RSI | 47.44 |
| MFI | 26.99 |
| MACD Single Line | 1.25 |
| MACD | -0.55 |
| Support | |
|---|---|
| First Resistance | 375.3 |
| Second Resistance | 363.7 |
| Third Resistance | 352.4 |
Orchid Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,650 | 165,000 | 100 |
| Week | 1,999 | 199,920 | 100 |
| 1 Month | 4,443 | 444,348 | 100 |
| 6 Month | 9,887 | 988,654 | 100 |
Orchid Pharma Result Highlights
Orchid Pharma Synopsis
NSE-Medical-Diversified
Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 556.97 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2022. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.| Market Cap | 1,591 |
| Sales | 636 |
| Shares in Float | 0.41 |
| No of funds | 22 |
| Yield |
| Book Value | 2.35 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 31 |
| Alpha | 0.21 |
| Beta | 0.75 |
Orchid Pharma
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 89.96% | 89.96% | 89.96% | |
| Mutual Funds | 2.45% | 2.45% | 2.45% | |
| Insurance Companies | ||||
| Foreign Portfolio Investors | 0.86% | 1.37% | 1.48% | |
| Financial Institutions/ Banks | 0.25% | 0.04% | 0.52% | |
| Individual Investors | 3.43% | 3.61% | 3.69% | |
| Others | 3.05% | 2.57% | 1.9% |
Orchid Pharma Management
| Name | Designation |
|---|---|
| Mr. Ram Gopal Agarwal | Chairman & Non-Exe.Director |
| Mr. Manish Dhanuka | Managing Director |
| Mr. Mridul Dhanuka | Whole Time Director |
| Mr. Arun Kumar Dhanuka | Non Executive Director |
| Mrs. Tanu Singla | Independent Director |
| Dr. Dharam Vir | Independent Director |
| Mr. Manoj Kumar Goyal | Independent Director |
| Mr. Mudit Tandon | Independent Director |
Orchid Pharma Forecast
Price Estimates
Orchid Pharma FAQs
What is Share Price of Orchid Pharma ?
Orchid Pharma share price is ₹390 As on 30 March, 2023 | 18:48
What is the Market Cap of Orchid Pharma ?
The Market Cap of Orchid Pharma is ₹1591.8 Cr As on 30 March, 2023 | 18:48
What is the P/E ratio of Orchid Pharma ?
The P/E ratio of Orchid Pharma is -82 As on 30 March, 2023 | 18:48
What is the PB ratio of Orchid Pharma ?
The PB ratio of Orchid Pharma is 2.5 As on 30 March, 2023 | 18:48